<< Previous article
Skin Microbiome Cong...
Next article > >
Introduction to Vali...

Biobanking

: 25 Sep 2019 - 26 Sep 2019

: London, United Kingdom

Sector: Clinical

Type: Conference


This event will bring together internationally recognised biorepositories, scientific pioneers from pharmaceutical companies, and academics to strengthen current knowledge in biosample management and their research applications.

 

Day One – Wednesday 25th September 2019

  • Chairman's Opening Remarks 
  • FinnGen: how to effectively collect and maintain 100,000 patient samples and utilising biobank clinical data to drive precision medicine, with the fundamental concepts of biobanking 
  • What are the factors that make it more difficult for academic biobanks to supply biosamples to industry? 
  • A case study of BioBank AS, a biorepository focused on nonhuman biosamples 
  • Regulatory hurdle to accessing biobanking for research, the implications, the workaround and possible improvements for regulators 
  • GDPR and the challenges in Biobanking 
  • We will look at what novel technologies and solution are available to remedy problems in cold-chain distribution. 
  • The importance of quality management systems in biobanking and guidelines for data quality improvement 
  • This case study session will give you first-hand account of the interaction of UK brain banks with academia and pharmaceutical industries researching neurological conditions. 
  • Biobanking: An R&D enabler for infectious disease diagnostics 
  • Chairman's Closing Remarks and Close of Day One 

 

Day Two – Thursday 26th September 2019

  • Chairman's Opening Remarks 
  • Connecting Biobanks with Public Molecular Archives: Achieving Maximum FAIRness of BioSamples 
  • Sustainable biobank cost recovery model case study
  • Human Pluripotent Stem Cells: Paving the way for clinical applications 
  • Increasing utilisation of Ukrainian biobanks by researchers to increase their significance
  • How biobanks and strategic partnerships can empower biosharing, by supporting precision medicine
  • The Evolution of ISBER (The International Society of Biological and Environmental Repositories) 
  • Challenges in sample standardisation for successful international biobank collaboration, how to drive precision medicine for cancer
  • The ME/CFS Biobank, a biobank specialised by disease and the current development of the EUROMENE network 
  • Chairman's Closing Remarks and Close of Day Two

 

Find out more

 

Venue

London
United Kingdom


Organizer

SMi Ltd.
Phone: +44 0 207 827 6186
Email: events@smi-online.co.uk
Visit: https://www.smi-online.co.uk/pharmaceuticals/


<< Previous article
Skin Microbiome Cong...
Next article > >
Introduction to Vali...